Active, Not Recruiting
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
NCT04531046
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory
- Locations
-
- CH Liège Liège, Belgium
- CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux, France
- CHU Clermont Ferrand - Hôpital Estaing Clermont-Ferrand, France
- APHP - Hôpital Henri Mondor Créteil, France